Skip to content
HealthTech Series B Founded 2020

Cellanome

Developer of the omic data platform for researchers

📍 Palo Alto, United States · Life Sciences Tech

Funding snapshot

Last roundSeries B
Amount$76M
Date23 December 2025

About

Developer of the omic data platform for researchers. The company has developed a multi-omics platform that uses synthetic biology and informatics methods.

Latest news

No articles yet.

Raising like Cellanome?

Analyze your pitch deck before your next raise.

Analyze My Deck →